Tremfya 100 MG/ML one-pressml
Ended Awarded Last action
- Contract number
- SPE2DR26FBTN9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,786
Award facts
- Contract value 100% obligated
- $22,786.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $22,786.02 to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 MG/ML, a pharmaceutical product used in the treatment of plaque psoriasis and other immune-mediated inflammatory diseases. This firm fixed-price delivery order, with an ultimate completion date of January 26, 2026, was competitively awarded without set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution location. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as the parent organization and holds the underlying IDC valued at $999,999,999.00 through December 31, 2031.
This award is part of DLA's broader pharmaceutical supply chain operations, which leverage indefinite delivery contracts to efficiently procure essential medications and medical supplies for military healthcare programs worldwide. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The short completion window reflects the urgent nature of pharmaceutical procurement for federal medical operations, while the firm fixed-price structure ensures cost predictability for the government.
Quick answers
Who was awarded contract SPE2DR26FBTN9?
SPE2DR26FBTN9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FBTN9 worth?
The government has obligated $22,786 on SPE2DR26FBTN9.
Is contract SPE2DR26FBTN9 an order under another contract?
Yes. SPE2DR26FBTN9 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTN9 competed?
The extent of competition for SPE2DR26FBTN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award